Cancer survivors face several challenges following the completion of active treatment, including uncertainty about late effects of treatment and confusion about coordination of follow-up care. The authors evaluated patient satisfaction with personalized survivorship care plans designed to clarify those issues. The authors enrolled 48 patients with breast cancer and 10 patients with colorectal cancer who had completed treatment in the previous two months from an urban academic medical center and a rural community hospital. Patient satisfaction with the care plan was assessed by telephone interview. Overall, about 80% of patients were very or completely satisfied with the care plan, and 90% or more agreed that it was useful, it was easy to understand, and the length was appropriate. Most patients reported that the care plan was very or critically important to understanding an array of survivorship issues. However, only about half felt that it helped them better understand the roles of primary care providers and oncologists in survivorship care. The results provide evidence that patients with cancer find high value in personalized survivorship care plans, but the plans do not eliminate confusion regarding the coordination of follow-up care. Future efforts to improve care plans should focus on better descriptions of how survivorship care will be coordinated.
their cancer and its treatment, including psychological distress, pain, impaired organ function, sexual dysfunction, cosmetic changes, and limitations in mobility, communication, and cognition (Ganz, 2000; Harrington, Hansen, Moskowitz, Todd, & Feuerstein, 2010; Hewitt, Greenfield, & Stovall, 2005; Stein, Syrjala, & Andrykowski, 2008; Strieker & Jacobs, 2008) . A landmark report by the Institute of Medicine (Hewitt et al., 2005) recognized that the system of delivering care to the growing number of cancer survivors was inadequate. Specifically, it suggested that the transition of medical care following cancer treatment often is not well coordinated, and many cancer survivors and providers are unaware of late effects and heightened health risks related to the cancer and its treatment. A key recommendation of the report was that patients with cancer completing primary treatment should be provided with a survivorship care plan that includes a comprehensive treatment and care summary and follow-up plan.
Although the Commission on Cancer (2012) added the provision of a survivorship care plan to its cancer program standards, sparse evidence exists regarding the effectiveness and optimal content of care plans (Salz, Oeffinger, McCabe, Layne, & Bach, 2012) . Two small studies of personalized survivorship care plans suggested reductions in unmet needs among cancer survivors and increased adherence with medical surveillance recommendations (Jefford et al., 2011; Oeffinger et al, 2011) . However, a randomized trial in Canada (Grunfeld et al., 2011) found that early-stage breast cancer survivors who received a survivorship care plan experienced no benefit in cancer-related distress, quality of life, patient satisfaction, and other measures after one year compared to patients who received only a standard discharge visit. Although the findings are limited by a short follow-up time and may not be directly generalizable to the United States, they provide impetus for additional research on the optimal format and delivery of cancer survivorship care plans (Smith & Snyder, 2011) .
The authors of the current article conducted a study of survivorship care plans for patients with breast or colorectal cancer in an urban academic medical center and a small rural community hospital in Vermont. The authors evaluated patients' satisfaction with the survivorship care plans and assessed the importance of various domains of the care plan for the patient. The results can be used to optimize the future design of care plans, which would maximize their usefulness to the patient.
Methods

Study Population
The current study was conducted at two sites: Fletcher Allen Health Care, an academic medical center in Burlington, VT, and the Norris Cotton Cancer Center-North, a rural extension of Dartmouth-Hitchcock Medical Center located at Northeastern Vermont Regional Hospital in St. Johnsbury. Eligible patients had stages 0-III breast cancer or stages II-IV colorectal cancer, were aged 18 years and older, and had completed treatment with curative intent within the preceding 12 months. The study was approved by the human subjects institutional review boards at the University of Vermont and Dartmouth Medical School, and all patients provided written informed consent. From January to July 2011, a total of 89 patients were invited to participate in the study and 78 agreed (88%), including 61 with breast cancer and 17 with colorectal cancer.
Survivorship Care Plans
Survivorship care plans were prepared by advanced practice providers (nurse practitioners and physician assistants) in consultation with oncologists at each study site using the Survivorship Care Plan Builder software tool developed by Journey Forward™ (Hausman, Ganz, Sellers, & Rosenquist, 2011) . Each survivorship care plan was developed using the Journey Forward templates for breast and colorectal cancer, and contained the following domains: a summary of the patient diagnosis, a summary of the patient's treatment, information on recommended follow-up tests and secondary cancer prevention, information received on late effects of cancer treatments, and a list of national and local healthpromotion resources. The survivorship care plan was delivered to and discussed with patients by the advanced practice providers during a care plan visit at the clinic. The visit lasted about one hour (range = 45-90 minutes) and occurred about 1-6 months following completion of initial oncologic treatment for cancer. The survivorship care plans were modified if necessary with patient input and finalized. A copy of the final survivorship care plan also was mailed to the patients' primary care providers. Although the care plan was added to patient electronic medical records and the oncologists were aware of the study, the oncologists were not directly notified of the care plans for their patients.
Data Collection
Telephone interviews were conducted with the patients about two months after the care plan visit. As many as 15 attempts were made to contact participants, including calls at varying times on weekdays, weeknights, and weekends, as well as voicemails left with a toll-free number to return calls. Of the 78 patients who enrolled in the study, 58 (74%) completed a telephone interview. The remaining 20 either refused to complete the telephone interview (n=6) or could not be contacted (n = 14). Nonrespondents were more likely to be older than age 65 years, but had similar patterns of cancer stage and treatment to those who completed the interview. The telephone interview included questions to assess the care plan as a whole, as well as questions targeted specifically toward the various domains and elements of the care plan. A variety of question types were used, including categorical response, Likert scale, and open-ended response. Patients also were asked to provide basic demographic information including marital status, education, and family income. Medical data, including cancer stage, date of diagnosis, and treatment information, were obtained from the patients' medical records.
Statistical Analyses
All statistical analyses were conducted using SAS ® , version 9. Descriptive statistics were prepared for each survey question of interest. For certain questions pertaining to the care plan in general, the complete set of response frequencies was described. For other questions, response options were collapsed into two groups for analysis. Response options for accuracy ("Was it accurate?") and ease of understanding ("Was it easy to understand?") of the various domains included "yes," "no," and "somewhat." The responses were categorized as agree ("yes") or did not agree ("no" or "somewhat"). Response options for whether the care plan was important in helping to understand general domains of survivorship (e.g., possible late effects of treatment) were dichotomized as "very important" or "critically important" and "somewhat important" or "not important at all." Response options for whether the care plan was important in helping to understand specific elements of the care plan (e.g., recommended frequency of follow-up tests) were dichotomized as agree ("yes") and did not agree ("no" or "not sure"). Tests for interaction by cancer site and facility type were conducted using Fisher's exact tests. The 95% confidence intervals were constructed using the Clopper-Pearson method for exact confidence limits for a binomial proportion (Clopper & Pearson, 1934) .
Results
A total of 58 patients completed the interview, including 48 with breast cancer and 10 with colorectal cancer. The median age of participants was 54 years (range = 35-75 years) among patients with breast cancer and 59 years (range = 41-70 years) among patients with colorectal cancer. All patients were non-Hispanic Whites, 74% were married or living as a couple, and more than 85% reported good, very good, or excellent health. Compared to patients with breast cancer, the patients with colorectal cancer were more likely to be aged 65 years and older, have less education, have more advanced cancers, and to have received chemotherapy (see Table 1 ).
In general, all patients were highly satisfied with the survivorship care plans (see Table 2 ). Among both cancer types, 46 patients (79%) were very or completely satisfied with the care plan, 53 (91%) agreed that the care plan was useful and easy to understand, and 54 (91%) said that the length was just right. Almost all patients found the in-person care plan visit useful and would recommend a care plan to others. However, seven patients with breast cancer (12%) and four patients with colorectal cancer (40%) reported that they would need help using the care plan. No statistically significant differences were noted in responses to these items between patients with breast or colorectal cancer (all p interaction ≥ 0.18).
When examined according to facility type, similar results for all patients combined (breast and colorectal) were obtained for the urban academic medical center (n = 37) and the rural community hospital (n = 21), with the exception of ease of understanding the care plan (data not shown). At the urban academic medical center, 30 patients (81%) strongly agreed and seven patients (19%) agreed that the care plan was easy to understand, compared to 10 (48%) and 9 (43%) at the rural community hospital, respectively, where an additional two patients (10%) neither agreed nor disagreed (p interaction = 0.01).
Analyses of specific care plan domains revealed that each section was rated very highly for accuracy and ease of understanding, with the exception of which doctor will order tests for recurrences or new cancers (see Table 3 ). Only 28 patients with breast cancer (58%) and seven with colorectal cancer (70%) understood which doctor would order these tests. About 50%-70% of patients with breast cancer reported that the care plan was very or critically important to helping them understand the various domains covered by the care plan. High levels of importance (80%-100%) were reported among patients with colorectal cancer. All patients reported that the section on tests needed in the future was the most important section for improving their understanding. Analyses according to facility type revealed no statistically significant differences, although a higher proportion of patients at the rural community hospital (n = 14,74%) found the care plan very or critically important for understanding their diagnosis compared to patients at the academic medical center (n = 17,49%) (p interaction = 0.09; data not shown).
The helpfulness of specific aspects of the care plan was further evaluated in the survey (see Figure 1 ). Among patients with breast cancer, 36 (75%) reported that the care plan helped them better understand the need for follow-up visits to check for late effects and 35 (73%) reported that the care plan helped them better understand the importance of healthpromoting practices following cancer treatment. For patients with breast cancer, the care plan was least helpful for understanding the frequency of follow-up tests (n = 25, 52%, found it helpful), how their primary care providers and oncologists will work together (n = 25, 52%), and the role of the primary care provider in their survivorship care (n = 24, 50%). Patients with colorectal cancer reported generally high levels of helpfulness for all elements, with the exception of their primary care providers' role in survivorship care (n = 4, 40%). The differences in those responses between patients with breast and colorectal cancer were not statistically significant. Analyses across facility type revealed that patients at the rural community hospital were more likely to find the care plan helpful in understanding how primary care providers and oncologists work together and the role of their primary care provider in survivorship care (n = 15 [71%] for both) than patients at the academic medical center (n = 18 [49%] and n = 13 [35%] patients, respectively) (p interaction = 0.1 and 0.03, respectively; data not shown).
Discussion
The current study found that patients with breast or colorectal cancer in academic and rural study sites in Vermont reported high satisfaction with survivorship care plans designed using the Survivorship Care Plan Builder from Journey Forward. The care plans were rated very highly for usefulness, ease of understanding, and accuracy, and most patients reported that the care plan was very or critically important in helping them understand the various domains covered by the care plan. The results suggest that survivorship care plans are useful tools for improving patients' understanding of their diagnosis, treatment, survivorship care, and health promotion.
The area of the care plan that was least favorably rated was the information regarding the coordination of care. Only about half of the patients felt that the care plan helped them better understand the role of their primary care provider in survivorship care and how their primary care provider and oncologist would work together. The care plan was effective in describing the types of tests needed for surveillance for recurrences and new cancers, but a substantial proportion of patients still did not understand who would order tests for recurrences or new cancers. That limitation of the care plan likely reflects the uncertainty in the medical community regarding the precise roles of oncologists and primary care providers in survivorship care (Potosky et al, 2011) . A survey by Salz et al. (2012) found that less than half of the survivorship care plans in use at National Cancer Institute-designated cancer centers indicated the medical provider who should perform specific medical surveillance. In addition, the inclusion of contact information for care coordinators or navigators in survivorship care plans is rare (Strieker et al, 2011) . The authors' results provide additional evidence that an urgent need exists for guidelines from professional societies and other organizations that can clarify the role of primary care providers and oncologists in survivorship care and reduce uncertainty for providers and patients.
Relationship to Previous Studies
The majority of previous studies regarding patient perspectives on survivorship care plans have used qualitative methods to assess patient preferences for survivorship care plans, most often by soliciting responses to a sample care plan (Salz et al., 2012) . The studies provided evidence that survivors prefer the inclusion of information such as diagnosis and treatment, expected side effects (physical and psychological), signs and symptoms of recurrence, a recommended follow-up schedule, and resources for health promotion, further information, and support (Baravelli et al., 2009; Brennan, Butow, Marven, Spillane, & Boyle, 2011; Burg, Lopez, Dailey, Keller, & Prendergast, 2009; Hewitt, Bamundo, Day, & Harvey, 2007; Marbach & Griffie, 2011; Smith, Singh-Carlson, Downie, Payeur, & Wai, 2011) . The current study provides quantitative evidence that breast and colorectal cancer survivors who receive a personalized survivorship care plan find value in those components of the care plan. The authors also found that cancer survivors considered the care plan visit highly useful. The results are consistent with prior studies suggesting that in-person care plan visits are generally positive experiences for patients and can reduce anxiety and stress related to cancer (Jefford et al., 2011; Mayer et al., 2012) .
In contrast, the focus group studies indicated that patients believe that survivorship care plans would be valuable for improving communication among providers of care (Brennan et al., 2011; Kantsiper et al., 2009; Marbach & Griffie, 2011) . The results suggest that current versions of survivorship care plans may not meet that goal.
The majority of previous studies regarding patient perspective on survivorship care plans have focused on patients with breast cancer. Unfortunately, the authors of the current article were unable to detect differences in care plan satisfaction between patients with breast and colorectal cancer because of the small number of patients with colorectal cancer enrolled in the current study.
Previous focus group studies have revealed no differences in preferences for care plan content among patients living in urban and rural settings . The authors of the current study observed few differences in patient evaluation of the care plan according to whether their care was received at an urban academic medical center or a rural community hospital, although those comparisons also were limited by a small sample. Patients at the community hospital were less likely to strongly agree that the care plan was easy to understand, but more than 90% indicated some level of agreement. Patients at the community hospital also found the care plan more important for understanding their diagnosis and for understanding how care would be coordinated. Some of the differences may be attributable to individual level factors such as income and health status, which were somewhat lower in the community hospital population. The results also could have been influenced by the style of delivery of the specific advanced practice providers at the two study sites.
Limitations
Certain limitations should be considered when interpreting the results of the current study. The lack of racial and ethnic diversity of patients seen at these clinics limits the generalizability of the results. Although the size of the study population was adequate to describe overall satisfaction with the care plans, insufficient power was available to detect small differences in responses by cancer type or type of facility. In addition, the participants who agreed to take part in the study were slightly younger than the target population of cancer survivors at the study clinics and may have differed in other unmeasured ways (e.g., attitudes toward medical care). Therefore, the findings require additional exploration in larger populations across a variety of healthcare settings.
Although the authors assessed patient satisfaction with the survivorship care plans at a single point in time, patient satisfaction with care plans may vary over time. The results should not be generalized to settings in which the document is not delivered during an in-person medical visit. Finally, responses to a series of questions regarding the helpfulness of the survivorship care plans will vary according to the quality of the care plan as well as the preexisting knowledge base of the patients. Although those questions provide a measure of the use of care plans in the patient population, the authors could not distinguish whether any lack of helpfulness was caused by a failure of the care plan document or simply because patients already possessed the knowledge.
Conclusion
Patients with breast and colorectal cancer were quite satisfied with the survivorship care plans and reported that the various components of the care plan were important in helping them understand their diagnosis, treatment, and survivorship care. Although the impact of survivorship care plans on health outcomes remains unclear, the results indicate that patients find them highly valuable. The survivorship care plans were most highly valued by patients for helping them understand the need for follow-up visits to check for late effects and the importance of health promoting practices following cancer treatment. Future efforts to improve survivorship care plans should focus on describing the coordination of survivorship care, including improved delineation of the specific roles of the primary care provider and oncologist.
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Implications for Practice
►
Survivorship care plans are useful tools for improving how patients with cancer understand their diagnosis, treatment, survivorship care, and health promotion.
► Survivorship care plans partially reduce patient uncertainty regarding the coordination of survivorship care between primary care providers and oncologists.
► Future efforts to ensure improved coordination of care will require improvements to current survivorship care plan designs and/or additional efforts beyond the provision of a survivorship care plan. 
